Core Insights - Hark Capital has closed a $50 million NAV facility with Pharos IV-A, L.P., aimed at supporting healthcare investments [1][2] - The financing will be utilized for both new and existing investments in Pharos' healthcare portfolio [1] - This transaction marks the third financing facility between Hark Capital and Pharos Capital Group, indicating a strong partnership [2] Company Overview: Hark Capital - Hark Capital, a subsidiary of P10, Inc., has been providing non-dilutive fund finance solutions since 2013, focusing on NAV-based and management company facilities [3] - The firm has deployed over $1.7 billion across more than 130 transactions with over 60 sponsors in the US, Canada, and Europe [3] Company Overview: Pharos Capital Group - Pharos Capital Group is a physician-founded investment firm based in Dallas and Nashville, focusing on healthcare companies that aim to reduce costs and improve patient outcomes [3] - As of June 30, 2025, Pharos has invested in 61 companies and manages over $900 million in private equity assets [3] - The firm typically invests between $25 million and $50 million in middle-market companies seeking growth funding [3]
Hark Capital provides $50 million NAV facility to Pharos Capital Group